ArticleMalaria journal2025
The impact of a humanitarian crisis on the magnitude of malaria in Tigray, Northern Ethiopia from 2014 to 2024.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Determinants of Delayed Malaria Treatment-Seeking Among Under-Five Children in a Post-Conflict District of Northern Ethiopia: A Facility-Based Unmatched Case-Control Study.Journal of epidemiology and global health · 2026Article
- Prevalence of malaria and diagnostic performance of malaria rapid diagnostic tests compared to microscopy among febrile patients at Pawe General Hospital, Northwest Ethiopia.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThough Ethiopia has made a remarkable effort towards malaria prevention and control activities, malaria is occurring at epidemic levels in different regions. In Tigray, the health system including the surveillance system was damaged due to the war that erupted in November 2020, which requested to assess the burden of malaria in the region. A noticeable lack of malaria is due to the humanitarian crisis (war). Therefore, this study aimed to describe the malaria situation in the Tigray region of Ethiopia from 2014 to 2024.
methodsA descriptive cross-sectional study design was conducted in January 2025 retrospectively data sourced from 2014 to 2024 in Tigray. Data was collected from the public health emergency management and health management information system database using a data abstraction tool. Data was cleaned and analysed through Microsoft Excel 2019 and ArcGIS 10.7. The analysed findings were presented using narratives, tables and graphs.
resultsAmong 7,195,545 suspected cases, 2,185,318 (30.37%) were confirmed malaria cases, yielding an average incidence rate of 35.37 per 1,000 people (95% CI 24.80-45.94) and a case fatality rate of 27 per 100,000. Plasmodium falciparum (65.3%) was the predominant species, followed by Plasmodium vivax (34.7%). The highest transmission was recorded in 2024 (382,955 cases), while the lowest was in 2021 (19,110 cases). During the conflict, report completeness decreased by 83%. Malaria cases peaked in autumn, with an average incidence rate of males and females at 50.19 and 25.31 per 1000, population, respectively, and individuals over 15 years old were 43.16 per 1000. Incidence was highest in the western zone (85/1,000) and lowest in the Eastern and Mekelle zones (7/1,000).
conclusionsThe magnitude of malaria was low during the crisis due to a very low notification rate, but the disease flared up and still became a major public health problem during the post-war period due to improved data access. Therefore, scaling-up vector control measures during high malaria transmission periods and geographical priorities for controlling and eliminating malaria to achieve the country's elimination strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.